FDA OKs Philips' ElastQ Imaging device

Royal Philips' ElastQ Imaging device earned market clearance from the Food and Drug Administration.

ElastQ aids in the diagnosis of various liver conditions, including hepatitis B and C, liver cancer and cirrhosis.

The device uses shear wave elastography to assess soft liver tissue for stiffness — a sign of issues with the organ — without the need for a liver biopsy.

ElastQ offers a larger field of vision, color-coded quantitative assessment of the tissue stiffness, and real-tine feedback and intelligent analysis, according to a news release.

More articles on supply chain:

Bernie Sanders introduces drug importation bill to lower medicine costs: 5 takeaways
Drug spending rose faster under ACA plans than other health plans
FDA: Drug manufacturing at Pfizer's Kansas plant is 'out of control'

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars